There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.
Abstract
We examined the physiological effects and tolerance of UroPhos-K, a slow release neutral
form of potassium phosphate (155 mg. phosphate and 8 mEq. potassium per tablet) in
patients with absorptive hypercalciuria.